OpenAI announced a new series of AI models built to help life sciences researchers work faster. Why it matters: Biology ...

OpenAI has officially entered the field of AI-assisted drug discovery, challenging competitors such as Google and triggering sharp declines in the stock prices of related publicly traded companies.

Mark Zuckerberg has spent billions trying to catch up in the AI race. On Wednesday, he showed the world what that money has ...